Richard Masana 
This article, 2/28 Stocks, focuses on providing stock market and financial advice. For today’s article, we will be addressing the market and making some picks moving forward.
Thoughts on the Market
The market finally had a correction last week after surging for quite awhile. I know I am still removing some of the lube from my butt hole. Nevertheless, all is not lost. This setback basically brought market levels back to where they were at the beginning of February. There is always a bull market somewhere and this dip gives us a terrific long-term buying opportunity.
2/28 Stocks
1. Paypal/Square – As of the time of the writing, these two big fintech hitters have lost some traction. Paypal is at $259.41 down from its February 16th high of $306.72. Meanwhile, Square is at $229.79 which represents a significant decrease from its February 16th high of $280.37. This comes despite tremendous continued growth. Load up for the future as electronic payments are certainly not decreasing anytime soon.
2. Nio/Churchill “Lucid” – Two weeks ago these were some of the hottest stocks on the block. These are the two of the three companies considered the long-term direct rivals to Tesla in the EV Space. People were tossing $60 a share on Churchill pre-merger. Nio is already selling tons of cars in China. Now the Churchill/Lucid merger is official and Churchill is down to $31.14 with Nio $46.95. For Churchill granted the value is due to an adjustment based on the merger value. However, we can stick these two in the long-term hold category.
3. NVIDIA – Back in the ranks, this week’s barrage brought NVIDIA’s price back down to $546.50 from $598.45. Nevertheless, I’d expect a very quick reversion back.
4. SOS/MARA – A week ago I wrote up SOS thinking it would hit $18-20 with Bitcoin kissing $58,000 over the weekend. Nonetheless, Bitcoin came crashing and brought the blockchain stocks with it. Now SOS is an absolute bargain, load up.
5. Moderna – Moderna has fallen from a high of $185.98 on February 8th down to a current price of $153.30. However, they are shipping out more vaccines than ever before and now have a vaccine that can address the variant waiting on FDA approval. Assuming that most Covid vaccines last a year or so, imagine the future business ahead. They clearly do this very well with only Johnson and Johnson and Pfizer in the mix. After Covid, I’d think cancer vaccines are the next big investment.
Make sure to hop in our Expert Discord Chat for FREE! Rich will be there answering questions all day and all night! Follow Rich on Twitter @JFan303 and be sure to be on the look out for future articles at https://windailysports.com/stocks/ . Rich is not a financial advisor, but merely an individual investor. He does own shares of all the stocks listed above.
